Covered recipient · General Payments record
ERIK SUPRATIK MITTRA
Allopathic & Osteopathic Physicians Nuclear Medicine
General Payments · PY2018–2024
$80,428.64
- Reported across 79 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Honoraria | $6,500.00 | 1 |
| Consulting Fee | $5,888.00 | 1 |
| Travel and Lodging | $1,831.86 | 6 |
| Food and Beverage | $683.89 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Curium US LLC | $8,410.64 | 8 |
| Bayer Healthcare LLC | $6,362.58 | 7 |
| TerSera Therapeutics LLC | $130.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Bayer Healthcare LLC | $210.90 | 11/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1086078880 | CMS |
| Bayer Healthcare LLC | $126.68 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086158964 | CMS |
| Bayer Healthcare LLC | $15.00 | 11/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086192300 | CMS |
| Bayer Healthcare LLC | $15.00 | 11/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086192302 | CMS |
| Bayer Healthcare LLC | $57.00 | 11/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086192304 | CMS |
| Bayer Healthcare LLC | $50.00 | 11/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086248568 | CMS |
| Bayer Healthcare LLC | $5,888.00 | 11/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1086248570 | CMS |
| Curium US LLC | $651.21 | 04/22/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1080546139 | CMS |
| Curium US LLC | $274.85 | 05/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1080546137 | CMS |
| Curium US LLC | $335.01 | 05/04/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1080546141 | CMS |
| Curium US LLC | $143.71 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1080546147 | CMS |
| Curium US LLC | $145.97 | 05/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1080546133 | CMS |
| Curium US LLC | $245.79 | 05/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1080546143 | CMS |
| Curium US LLC | $6,500.00 | 05/15/2024 | Honoraria | Undisputed | 01/23/2026 | 1080546135 | CMS |
| Curium US LLC | $114.10 | 05/15/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1080546145 | CMS |
| TerSera Therapeutics LLC | $130.53 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144714331 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.